Akso Health Group Stock-Based Compensation Growth & History (AHG)
Akso Health Group's stock-based compensation was $0 for fiscal 2024.
View full Akso Health Group company overviewAkso Health Group annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-03-31 | $0 | $0 | — |
| 2023 | 2023-03-31 | $0 | −$391,625 | — |
| 2022 | 2022-03-31 | $391,625 | $336,157 | +606.04% |
| 2021 | 2021-03-31 | $55,468 | −$291,998 | −84.04% |
| 2020 | 2020-03-31 | $347,466 | −$6.2M | −94.72% |
| 2019 | 2019-03-31 | $6.6M | $4.8M | +260.08% |
| 2018 | 2018-03-31 | $1.8M | $1.8M | — |
| 2017 | 2017-03-31 | $0 | $0 | — |
| 2016 | 2016-03-31 | $0 | — | — |
Akso Health Group stock-based compensation trends
Over the last five fiscal years, Akso Health Group's stock-based compensation decreased from $6.6M to $0, a change of −$6.6M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Akso Health Group source filings ↗